SNSE- Sensei Biotherapeutics, Inc.

Name: Sensei Biotherapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Sensei Biotherapeutics, Inc. (SNSE) has 9 insiders with recent SEC Form 4 filings, including 9 buys and 4 sells. SNSE is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
COO	Parikh Anand Kiran	1.24M	$29.00M	-
?	Cambrian Biopharma Inc	155.6K	$3.64M	-
Other	Craver Josiah	80.0K	$1.87M	-
Dir	Donenberg Phillip B.	23.1K	$540.5K	-
Dir	Holmen Bob	19.0K	$444.6K	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 17, 2021	Peyer James	Director, 10% Owner	Buy	117	$5.29	$618.93	-	-56.2%	-75.9%
Dec 16, 2021	Peyer James	Director, 10% Owner	Buy	10,925	$5.25	$57,356.25	+0.2%	-51.0%	-72.5%
Dec 16, 2021	Cambrian Biopharma Inc	10% Owner	Buy	10,925	$5.25	$57,356.25	+0.2%	-51.0%	-72.5%
Dec 10, 2021	Ricks Thomas G48	Director	Buy	40,000	$6.24	$249,600.00	+6.4%	-47.1%	-71.9%
Aug 11, 2021	Pierce Robert Hamilton63	Chief Scientific Officer	Sell	16,030	$7.34	$117,717.91	-100%	+7.9%	-73.1%
Aug 10, 2021	Pierce Robert Hamilton63	Chief Scientific Officer	Sell	79,792	$7.12	$568,245.57	-29.8%	+21.3%	-70.8%
May 5, 2021	Cambrian Biopharma Inc	10% Owner	Buy	350	$12.00	$4,200.00	-	-38.3%	-86.8%
May 5, 2021	Peyer James	Director, 10% Owner	Buy	350	$12.00	$4,200.00	-	-38.3%	-86.8%
Apr 20, 2021	Cambrian Biopharma Inc	10% Owner	Buy	385	$12.77	$4,916.45	-	-46.1%	-85.1%
Apr 20, 2021	Peyer James	Director, 10% Owner	Buy	385	$12.77	$4,916.45	-	-46.1%	-85.1%

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC